Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Net Cash Flow (2016)

Lixte Biotechnology Holdings' Net Cash Flow history spans 7 years, with the latest figure at -$469842.0 for Q4 2016.

  • For Q4 2016, Net Cash Flow changed N/A year-over-year to -$469842.0; the TTM value through Dec 2016 reached $174648.0, up 0.87%, while the annual FY2025 figure was $4.1 million, 228.55% up from the prior year.
  • Net Cash Flow reached -$469842.0 in Q4 2016 per LIXT's latest filing, down from $573995.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $7.2 million in Q1 2014 to a low of -$469842.0 in Q4 2016.
  • Average Net Cash Flow over 5 years is $959797.0, with a median of $285354.5 recorded in 2013.
  • Peak YoY movement for Net Cash Flow: surged 11473.47% in 2012, then plummeted 616.03% in 2013.
  • A 5-year view of Net Cash Flow shows it stood at $1.7 million in 2012, then plummeted by 71.3% to $475019.0 in 2013, then skyrocketed by 1411.76% to $7.2 million in 2014, then tumbled by 98.73% to $91042.0 in 2015, then crashed by 616.07% to -$469842.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Net Cash Flow are -$469842.0 (Q4 2016), $573995.0 (Q3 2016), and -$3610.0 (Q2 2016).